Author:
Kim D.Y.,Kim J.H.,Lee S.-H.,Kim T.Y.,Heo D.S.,Bang Y.-J.,Kim N.K.
Reference17 articles.
1. A phase III randomized study of 5-fluorouracil and cisplatin versus fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of gastric cancer;Kim;Cancer,1993
2. Preliminary analysis of a randomized phase III trial of FAMTX versus ELF versus cisplatin/5-FU in advanced gastric cancer. A trial of the EORTC gastrointestinal tract cancer cooperative group and AIO;Wilke;Proc Am Soc Clin Oncol,1995
3. Oxaliplatin: mechanism of action and antineoplastic activity;Raymond;Semin Oncol,1998
4. Oxaliplatin plus 5-fluorouracil: clinical experience in patients with advanced colorectal cancer;Bleoiberg;Semin Oncol,1998
5. Oxaliplatin: a review of preclinical and clinical studies;Raymond;Ann Oncol,1998